211 related articles for article (PubMed ID: 26334958)
1. TRIP-Br1 oncoprotein inhibits autophagy, apoptosis, and necroptosis under nutrient/serum-deprived condition.
Jung S; Li C; Duan J; Lee S; Kim K; Park Y; Yang Y; Kim KI; Lim JS; Cheon CI; Kang YS; Lee MS
Oncotarget; 2015 Oct; 6(30):29060-75. PubMed ID: 26334958
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory role of TRIP-Br1 oncoprotein in hypoxia-induced apoptosis in breast cancer cell lines.
Li C; Jung S; Yang Y; Kim KI; Lim JS; Cheon CI; Lee MS
Int J Oncol; 2016 Jun; 48(6):2639-46. PubMed ID: 27035851
[TBL] [Abstract][Full Text] [Related]
3. Nutrient/serum starvation derived TRIP-Br3 down-regulation accelerates apoptosis by destabilizing XIAP.
Li C; Jung S; Lee S; Jeong D; Yang Y; Kim KI; Lim JS; Cheon CI; Kim C; Kang YS; Lee MS
Oncotarget; 2015 Apr; 6(10):7522-35. PubMed ID: 25691055
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory Role of TRIP-Br1/XIAP in Necroptosis under Nutrient/Serum Starvation.
Sandag Z; Jung S; Quynh NTN; Myagmarjav D; Anh NH; Le DT; Lee BS; Mongre RK; Jo T; Lee M
Mol Cells; 2020 Mar; 43(3):236-250. PubMed ID: 32050753
[TBL] [Abstract][Full Text] [Related]
5. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory role of TRIP-Br1 oncoprotein in anticancer drug-mediated programmed cell death via mitophagy activation.
Jung S; Myagmarjav D; Jo T; Lee S; Han S; Quynh NTN; Anh NH; Vu SH; Choi Y; Lee MS
Int J Biol Sci; 2022; 18(9):3859-3873. PubMed ID: 35813469
[TBL] [Abstract][Full Text] [Related]
7. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M
Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198
[TBL] [Abstract][Full Text] [Related]
8. The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1.
Gupta S; Takhar PP; Degenkolbe R; Koh CH; Zimmermann H; Yang CM; Guan Sim K; Hsu SI; Bernard HU
Virology; 2003 Dec; 317(1):155-64. PubMed ID: 14675634
[TBL] [Abstract][Full Text] [Related]
9. The complex of TRIP-Br1 and XIAP ubiquitinates and degrades multiple adenylyl cyclase isoforms.
Hu W; Yu X; Liu Z; Sun Y; Chen X; Yang X; Li X; Lam WK; Duan Y; Cao X; Steller H; Liu K; Huang P
Elife; 2017 Jun; 6():. PubMed ID: 28656888
[TBL] [Abstract][Full Text] [Related]
10. Up-Regulation of Glioma-Associated Oncogene Homolog 1 Expression by Serum Starvation Promotes Cell Survival in ER-Positive Breast Cancer Cells.
Xu J; Huang G; Zhang Z; Zhao J; Zhang M; Wang Y; Liu Z; Lu J
Cell Physiol Biochem; 2015; 36(5):1862-76. PubMed ID: 26182949
[TBL] [Abstract][Full Text] [Related]
11. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
12. TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1.
Hsu SI; Yang CM; Sim KG; Hentschel DM; O'Leary E; Bonventre JV
EMBO J; 2001 May; 20(9):2273-85. PubMed ID: 11331592
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways.
Zhang L; Wang H; Xu J; Zhu J; Ding K
Toxicol Lett; 2014 Aug; 228(3):248-59. PubMed ID: 24875536
[TBL] [Abstract][Full Text] [Related]
14. The TRIP-Br family of transcriptional regulators is essential for the execution of cyclin E-mediated cell cycle progression.
Sim KG; Cheong JK; Hsu SI
Cell Cycle; 2006 May; 5(10):1111-5. PubMed ID: 16721052
[TBL] [Abstract][Full Text] [Related]
15. Identification of PP2A as a novel interactor and regulator of TRIP-Br1.
Zang ZJ; Gunaratnam L; Cheong JK; Lai LY; Hsiao LL; O'Leary E; Sun X; Salto-Tellez M; Bonventre JV; Hsu SI
Cell Signal; 2009 Jan; 21(1):34-42. PubMed ID: 18940248
[TBL] [Abstract][Full Text] [Related]
16. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
17. p34SEI-1 inhibits apoptosis through the stabilization of the X-linked inhibitor of apoptosis protein: p34SEI-1 as a novel target for anti-breast cancer strategies.
Hong SW; Kim CJ; Park WS; Shin JS; Lee SD; Ko SG; Jung SI; Park IC; An SK; Lee WK; Lee WJ; Jin DH; Lee MS
Cancer Res; 2009 Feb; 69(3):741-6. PubMed ID: 19176394
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway.
Wang F; Li L; Chen Z; Zhu M; Gu Y
Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965
[TBL] [Abstract][Full Text] [Related]
19. Silibinin induces cell death through reactive oxygen species-dependent downregulation of notch-1/ERK/Akt signaling in human breast cancer cells.
Kim TH; Woo JS; Kim YK; Kim KH
J Pharmacol Exp Ther; 2014 May; 349(2):268-78. PubMed ID: 24472723
[TBL] [Abstract][Full Text] [Related]
20. Guttiferone K induces autophagy and sensitizes cancer cells to nutrient stress-induced cell death.
Wu M; Lao Y; Xu N; Wang X; Tan H; Fu W; Lin Z; Xu H
Phytomedicine; 2015 Sep; 22(10):902-10. PubMed ID: 26321739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
